ReNerve Limited (ASX:RNV)

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023
Medical Devices For Damaged Peripheral Nerves	510.36K	271.71K	177.37K	128.49K
Total	510.36K	271.71K	177.37K	128.49K

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023
New Zealand	2.31K	738.00	789.00	-
United States	508.05K	267.87K	176.58K	-
Hong Kong	-	3.10K	-	-
Australia	-	-	-	128.49K
Total	510.36K	271.71K	177.37K	128.49K

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 18, 2026

Data Sources Report a data error